Abbvie Inc (ABBV)

Mar 21, 2025, 12:59 PM EDT - 4 days ago

2025 Dividend Kings: Strong Run Continues

ABM ABT ADM AWR BDX BKH CWT

Mar 20, 2025, 9:40 AM EDT - 5 days ago

My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys

AAPL AGNC AM APLE ARCC ARI AVGO

Mar 18, 2025, 1:03 PM EDT - 7 days ago

Widely used drugs on US imports list from Europe

AMGN

Mar 15, 2025, 8:00 AM EDT - 10 days ago

ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

Mar 14, 2025, 6:08 PM EDT - 11 days ago

Drugmakers agree to participate in second round of price negotiations

AZN GSK MRK NVO TEVA

Mar 13, 2025, 3:55 PM EDT - 12 days ago

AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk

Mar 12, 2025, 1:39 PM EDT - 13 days ago

Calls of the Day: United Airlines, Delta, IBM, Abbvie, Uber

DAL IBM UAL UBER

Mar 11, 2025, 1:40 PM EDT - 14 days ago

Stocks beating the stock market's recent Trump slump have this in common

AMGN BAX CVS GILD PM SMCI TPL

Mar 11, 2025, 1:14 PM EDT - 14 days ago

AbbVie Inc. (ABBV) Leerink Partners Global Healthcare Conference (Transcript)

Mar 11, 2025, 1:00 PM EDT - 14 days ago

Siri & Glimstad Defeats AbbVie's Motion to Dismiss Illinois GIPA Lawsuit

Mar 8, 2025, 4:00 PM EST - 17 days ago

Darst's Stock Picks: GOLD, EL, ABBV

EL GOLD

Mar 5, 2025, 2:59 PM EST - 20 days ago

AbbVie Inc. (ABBV) TD Cowen 45th Annual Health Care Conference (Transcript)

Mar 5, 2025, 1:31 PM EST - 20 days ago

5 Big Biopharmaceutical Stocks That Are Finding Favor

AMGN GILD JNJ LLY

Mar 5, 2025, 9:00 AM EST - 20 days ago

The Dividend Aristocrats Ranked By Quality Scores: March 2025

ABT ADM ADP AFL ALB AMCR AOS

Mar 4, 2025, 2:59 PM EST - 21 days ago

Healthy Returns: AbbVie is the newest potential weight loss drug market player

Mar 4, 2025, 8:00 AM EST - 21 days ago

AbbVie to Present at the Leerink Partners Global Healthcare Conference

Mar 3, 2025, 2:07 PM EST - 22 days ago

AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race

Mar 3, 2025, 2:01 PM EST - 22 days ago

AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal

Mar 3, 2025, 1:21 PM EST - 22 days ago

Final Trades: Taiwan Semi, Abbvie, Tradeweb Markets and the IYH

TSM TW IYH

Mar 3, 2025, 1:45 AM EST - 22 days ago

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

Feb 28, 2025, 2:00 AM EST - 25 days ago

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

Feb 26, 2025, 8:00 AM EST - 27 days ago

AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference

Feb 24, 2025, 7:30 AM EST - 4 weeks ago

Don't Get Left Behind - The Great Rotation Into Dividend Stocks Is Here

AM AMZN BMY CSL GOOG GOOGL LMT

Feb 23, 2025, 11:52 AM EST - 4 weeks ago

Why AbbVie Remains A Strong Buy For Long-Term Investors

Feb 20, 2025, 10:18 AM EST - 4 weeks ago

How Dividend Investing Helps Parents Fund College Education Fees

MSFT O

Feb 19, 2025, 12:26 PM EST - 4 weeks ago

AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant

JNJ

Feb 19, 2025, 8:10 AM EST - 4 weeks ago

My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys

AAPL AGNC AM APLE ARCC ARI AVGO

Feb 19, 2025, 8:00 AM EST - 4 weeks ago

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Feb 18, 2025, 10:55 PM EST - 4 weeks ago

AbbVie Appears Ready To Move Higher

Feb 14, 2025, 11:58 AM EST - 5 weeks ago

The Big 3: ABBV, EA, CEG

EA CEG

Feb 14, 2025, 11:00 AM EST - 5 weeks ago

AbbVie: An Undervalued Dividend Aristocrat

Feb 14, 2025, 7:40 AM EST - 5 weeks ago

AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors

Feb 14, 2025, 7:30 AM EST - 5 weeks ago

All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On

AM CAT CME CNQ CP CSL DE

Feb 13, 2025, 11:57 AM EST - 5 weeks ago

AbbVie Declares Quarterly Dividend

Feb 12, 2025, 8:30 AM EST - 5 weeks ago

Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training

Feb 8, 2025, 8:00 AM EST - 6 weeks ago

Income Strategy: I'm Stashing Cash Into These Wonderful Dividends

PFE

Feb 7, 2025, 1:38 PM EST - 6 weeks ago

US FDA approves AbbVie's treatment for intra-abdominal infections

Feb 7, 2025, 1:27 PM EST - 6 weeks ago

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options

Feb 6, 2025, 8:05 AM EST - 6 weeks ago

Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign

Feb 3, 2025, 11:31 AM EST - 7 weeks ago

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

IDXX MOH

Feb 3, 2025, 10:36 AM EST - 7 weeks ago

Trump gives a lift to healthcare stocks with comments on Medicare and Medicaid

CNC ELV GILD HCA MOH

Feb 3, 2025, 9:25 AM EST - 7 weeks ago

Buy, Sell, Or Hold ABBV Stock At $185?

Feb 2, 2025, 7:30 AM EST - 7 weeks ago

2 Undervalued Dividend Stocks Ready For A Major Comeback

NSC

Jan 31, 2025, 4:39 PM EST - 7 weeks ago

AbbVie Q4 Earnings: Strong Revenue Results, Ambitious Forecasts - A Buy With Caveats

Jan 31, 2025, 2:52 PM EST - 7 weeks ago

AbbVie Q4 Earnings: Good 2025 Outlook Despite Enhanced Old And New Headwinds

Jan 31, 2025, 12:26 PM EST - 7 weeks ago

AbbVie Inc. (ABBV) Q4 2024 Earnings Call Transcript

Jan 31, 2025, 10:41 AM EST - 7 weeks ago

AbbVie Stock Soars as Biotech Tops Sales Estimates, Raises Outlook

Jan 31, 2025, 8:30 AM EST - 7 weeks ago

AbbVie's newer immunology drugs are offsetting Humira's decline, sending stock up 4%

Jan 31, 2025, 7:40 AM EST - 7 weeks ago

AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs

Jan 31, 2025, 7:36 AM EST - 7 weeks ago

AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results